MiniMed Go system

The system remembers your insulin doses, reminds you when more is needed, and recommends smart actions, so you can focus on feeling your best.1​



Good to go for ages 2 and up.

 

MiniMed Go system

Remembers. Reminds. Recommends. 
So you don’t have to.


Proper pairing, connectivity, and settings required or incorrect dosing and serious injury can occur. Ages 2-6 require caregiver supervision. See user guide for full details.

Remembers your insulin doses
Automatically logs doses on your smartphone so there's less to keep track of.
 

Reminds you when more insulin is needed
Alerts you when you need more insulin to help keep your levels in range.
 

Recommends smart actions
Uses your glucose and active insulin levels to determine if you need a dose, and tells you how much to take.
 

Now at your pharmacy, covered by major commercial health plans

Pay as little as $60 for one month of Instinct sensors.
If your copay exceeds $60, savings are automatically applied — no extra steps needed.

Pay as little as $125 for the InPenTM smart insulin pen. 
One pharmacy copay covers a smart insulin pen that lasts 12 months. And you may pay even less — average InPen copays range from $30–$90. If your copay exceeds $125, savings are automatically applied.

Terms and conditions apply.

Meet the MiniMed Go system

InPenTM smart insulin pen

Add icon collapse icon

A reusable smart insulin pen that sends data to the MiniMed Go app, automating insulin dose tracking. Offers half-unit dosing. Comes in 3 color options: blue, gray, and pink.

inpen amimation

Instinct sensor, made by Abbott

Add icon collapse icon

Instinct sensor is small, discreet1 and comfortable2 to wear with one-hour warm-up period.

Instinct sensor

MiniMed Go app

Add icon collapse icon

Integrates real-time glucose (CGM) monitoring, insulin dose tracking, and dose calculations and logging in a single app.3 Easily share reports with your healthcare provider. Check app compatibility.

 

 

MiniMed Go app

Simple set up. Seamless start.

All your onboarding happens in the MiniMed Go app, so you can get started when it's convenient for you.

After you're on therapy, we offer 24/7 support when you need it.

Tech specs

Indications for use

For people with diabetes.

  • InPen:  All ages, ages 2–6 require adult caregiver supervision.
  • Instinct sensor: All ages, ages 2–6 require adult caregiver supervision.
  • Simplera sensor: 18 years and over

Connectivity

  • InPen to app: Bluetooth® Low Energy (BLE) and Near Field Communications (NFC)
  • Sensors to app: Bluetooth® Low Energy (BLE) v4.2, 2.402–2.480 GHz, GFSK modulation, minimum 20 ft (6.09 m) line-of-sight range

Alert ranges

Instinct sensor

  • ≤ 55 mg/dL. Always active; cannot be disabled or adjusted.
  • Low alert limit range: 60–100 mg/dL (user-adjustable)
  • High alert limit range: 120–400 mg/dL (user-adjustable)
     

SimpleraTM sensor


  • Urgent low glucose alert: ≤ 64 mg/dL. Always active; cannot be disabled or adjusted
  • Low alert limit range: 65–90 mg/dL (user-adjustable)
  • High alert limit range: 100–400 mg/dL (user-adjustable)
  • Alert before low: Up to 60 minutes before predicted low; adjustable down to 10 minutes
  • Alert before high: Adjustable lead time
  • Low glucose alert detection rate: 94.7% correct detection rate; 5.3% missed detection rate (≤70 mg/dL, 30-minute detection window, arm insertion, adults)
  • High glucose alert detection rate: 98.6% correct detection rate; 1.4% missed detection rate (≥180 mg/dL, 30-minute detection window, arm insertion, adults)

Compatible insulin

The MiniMed Go system is intended for use with the following compatible U-100 insulins:

• U-100 HumalogTM*
• U-100 NovoLogTM*
• U-100 FiaspTM*

Battery

The InPen is a reusable device with a non-replaceable battery designed to last for one year, after which is must be replaced.

Warranty

InPen: One year

Frequently asked questions

Add icon collapse icon

What is the MiniMed Go system?

Add icon collapse icon

The MiniMed Go system is a diabetes management system combining the InPenTM smart insulin pen, a compatible continuous glucose monitor, and the MiniMed Go mobile app. Together, these technologies help you deliver the right dose at the right time.

Who can use MiniMed Go?

Add icon collapse icon

When used with Instinct CGM, the app is indicated for patients ages 7 years and older, or patients ages 2 to 6 years under the supervision of an adult caregiver. When used with Simplera CGM, the app is indicated for patients ages 18 and over. If using InPen alone, the app is intended for all ages, with patients under age 7 requiring supervision. 

Can I use another company’s CGM with this system?

Add icon collapse icon

No, the only compatible sensors for the MiniMed Go system are the SimpleraTM sensor and Instinct sensor.

How close does the app need to be to the insulin pen to not lose connection?

Add icon collapse icon

For pairing, the InPen must be within 3 feet (1 meter) of the MiniMed Go app. The InPen does not need to stay within range of the MiniMed Go app unless a dose is being administered. The pen and app must be within 3 feet (1 meter) for data to be sent. 

 

Make sure the MiniMed Go app and the sensor are located within 20 feet to ensure glucose data is being communicated.

What’s the difference between MiniMed FlexTM and MiniMed Go?

Add icon collapse icon

MiniMed FlexTM is an automated insulin delivery system that uses an insulin pump. MiniMed Go is a smart multiple daily injection system.

How long is the warranty?

Add icon collapse icon

MiniMed warrants the InPen smart insulin pen against defects in materials and workmanship for a period of 1 year from the date of purchase. 

Can I get MiniMed Go if I do not have a compatible smartphone?

Add icon collapse icon

If you don’t have a compatible smartphone, we can provide an App App Manager — a separate device that gives you access to the MiniMed Go app. 

Get started with the MiniMed Go system

Submit the form below and our team will process your request. You can change the insulin pen color before the order is placed.

What's in your system:

  • Blue InPen smart insulin pen
  • One month supply of Instinct sensor
  • Instructions on downloading the MiniMed Go app

indicates a required field.

Are you a MiniMed customer?

This field is required.
This field is required.
This field is required.
This field is required.
This field is required.
*
This field is required.
*
This field is required.
*
This field is required.
*
This field is required.
*
This field is required.
*
This field is required.
*
This field is required.

This form is for customers in the Unites States only. For more information about our products in your region please see our list of international locations.

How can we communicate with you?
This field is required.

HIPAA Marketing Authorization

MiniMed respects the privacy of all our customers. With your permission, we may use your protected health information, including your contact information and health-related data, for marketing purposes, promotional offers, survey opportunities, and advertising that we think may be of interest to you. We may also share your information with MiniMed representatives and contractors who are assisting us with these activities.

I understand that this Authorization may permit MiniMed to contact me by text message, telephone, or email. With respect to text messages, I consent to receiving text messages at the phone number(s) submitted using automated technology from or on behalf of MiniMed, concerning the marketing, advertising, and/or offers of sale of MiniMed products, therapies, and services. I also certify that I am (a) age 18 or older and (b) authorizing and consenting to use of the information provided for MiniMed to contact me. My consent is not a condition for purchase. Airtime, message, and data rates may apply. I may opt out at any time by (i) texting "STOP" in reply to a text; (ii) sending an email to takecontrol@medtronic.com; or (iii) signing into my MiniMed myHome profile and updating my communication preferences (www.diabetes.shop/communication).

Please note that this Authorization is optional, and you may refuse to opt in. If you do not want to opt in, it will not affect your treatment, health insurance eligibility, or benefits, and you will not be stopped or prevented from accessing the CareLink™ Personal system, or other MiniMed products, mobile apps, or services.

This Authorization will expire ten (10) years from the date you submit it online. You may revoke it by:

Opting out will not affect actions already taken. Information disclosed may be re-disclosed and no longer protected by federal privacy standards. Questions? Contact Customer Service at 800-646-4633 or takecontrol@medtronic.com.

This field is required.

If you arrived on this site via a social media platform, by submitting this form you agree that Medtronic Diabetes may share your visit to this site with that platform. This information may be used and/or re-disclosed by the originating site under their own privacy practices. See our Privacy Policy for more information. Click here to request information without submitting this form.

Thank you!

We've received your request – we'll be in touch with product information soon.

Oops!

Something went wrong. Please try again later.

Footnote
† Age indication: When used with the Instinct sensor, the app is indicated for patients 7+ years; for ages 2–6, use under adult caregiver supervision. When used with Simplera CGM, the app is indicated for patients ages 18 and over.

References

  1. Proper pairing, connectivity, and settings required. Talk to your healthcare professional before establishing and changing your settings. Ensure that all doses taken with InPen are logged in the app, that all doses taken with a device other than InPen are logged manually in the app, and that glucose and meal information entered into the dose calculator are current and accurate. Not doing so can result in incorrect dosing, hypoglycemia or hyperglycemia, and serious injury.
  2. Data on file, Abbott Diabetes Care, Inc.​​
  3. Why CGM alone is not enough: low actionability of CGM alerts without considering impact of active insulin.  M.B. Smith, G.Im, J. MacLeod, R.A. Vigersky; Abstract #758.  59th annual EASD meeting 5 Oct 2023.  (actionability of CGM alerts)

InPen Copay Program terms and conditions

  • Open to insured patients and patients with commercial prescription insurance and those who are not enrolled in any government-funded program that pays for prescription devices or treatments.
  • Excluded participants include patients enrolled in any federal, state, or government-funded healthcare program such as Medicare, Medicare Advantage, Medicare Part D, Medicaid, Medigap, Veterans Affairs (VA), the Department of Defense (DoD) or TRICARE® that provides coverage for InPen, or where prohibited by law.
  • Cash Discount Cards and other non-insurance plans are not valid as primary under this offer.
  • Offer subject to change or discontinue without notice. This is not health insurance.
  • Offer applies to a maximum of 1 prescribed InPen per Patient per benefit year.
  • Offer good only in the USA at participating pharmacies and cannot be redeemed at government-subsidized clinics.

Important safety information: MiniMed Go system

The MiniMed Go system includes the MiniMed Go app, InPen smart insulin pen injector and either the Instinct continuous glucose monitoring (CGM) sensor or Simplera CGM sensor. The system is intended to aid in diabetes management through multiple daily injections of compatible rapid-acting insulins (Humalog, Novolog, or Fiasp). The app and system components each require a prescription. When used with Instinct CGM, the app is indicated for patients ages 7 years and older, or patients ages 2 to 6 years under the supervision of an adult caregiver. When used with Simplera CGM, the app is indicated for patients ages 18 and over. If using InPen alone, the app is intended for all ages, with patients under age 7 requiring supervision. Use of these systems requires, among other things, adequate hearing and vision, a compatible mobile device and operating system, an open app, adequate pairing and connectivity, proper setting, use of an approved rapid-acting insulin, mobile device battery power, proper settings, accurate manual logging of insulin doses administered by means other than InPen, and occasional blood glucose meter (BGM) readings. Establishment of settings and treatment decisions should be made in consultation with a healthcare professional and on the basis of a combination of glucose readings, trend arrows, glucose target, active alerts, and recent events (such as insulin doses, exercise, meals, and medications). Failure to observe these and other details as found in the user guides can result in incorrect dosing, missed alerts and notifications, and ultimately hypoglycemia or hyperglycemia, with serious injury or death possible. For additional safety information and user guides, see https://bit.ly/MiniMedRisks.